Signature Resources Capital Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Signature Resources Capital Management, LLC
- $112 Billion
- Q4 2024
A detailed history of Signature Resources Capital Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 180 shares of ARWR stock, worth $3,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 180
-0.0%
Holding current value
$3,736
Previous $3.49 Million
2.95%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.5MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$326 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$254 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$185 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$132 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$101 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.2B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...